Patents by Inventor Masaya Obayashi

Masaya Obayashi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pollen allergy-related gene 513
    Patent number: 6986990
    Abstract: T cells from multiple subjects who showed different cedar pollen specific IgE titers were prepared before and after cedar pollen dispersal, and differential display analysis was performed to screen for pollen antigen responsive genes. As a result, a novel gene was successfully isolated whose expression is significantly higher in subjects with high cedar pollen specific IgE titer. The inventors have found that it is possible to use this gene to test for an allergic disease and to screen for candidate compounds for therapeutic drugs for an allergic disease.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: January 17, 2006
    Assignee: Genox Research, Inc.
    Inventors: Takeshi Nagasu, Yuji Sugita, Tomoko Fujishima, Tadahiro Oshida, Masaya Obayashi, Shigemichi Gunji, Izumi Obayashi, Yukiho Imai, Nei Yoshida, Kaoru Ogawa, Keiko Matsui
  • Method of examining for allergic disease
    Publication number: 20040058351
    Abstract: The differential display method was used to search for a gene whose expression level in eosinophils of patients with atopic dermatitis. As a result, 17 genes showing a significant increase in expression in eosinophils of light patients were isolated. These gene are usable in testing for an allergic disease and screening for a candidate compound for a therapeutic agent therefor an allergic disease.
    Type: Application
    Filed: August 11, 2003
    Publication date: March 25, 2004
    Inventors: Yuji Sugita, Ryoichi Hashida, Kaoru Ogawa, Takeshi Nagasu, Hirohisa Saito, Masaya Obayashi
  • Method of examining allergic disease
    Publication number: 20040053282
    Abstract: The differential display method was used to search for a gene whose expression level in eosinophils of patients with atopic dermatitis. As a result, intersectin 2 was isolated as a gene showing a significant increase in expression in eosinophils of light patients. The gene is usable in testing for an allergic disease and screening for a candidate compound for a therapeutic agent therefor an allergic disease.
    Type: Application
    Filed: August 11, 2003
    Publication date: March 18, 2004
    Inventors: Yuji Sugita, Ryoichi Hashida, Kaoru Ogawa, Takeshi Nagasu, Eiki Takahashi, Hirohisa Saito, Masaya Obayashi